《極限返航》再創新里程碑！全球票房突破6億美金大關 Ivar AI

Abcnews.com

SpaceX's IPO is set to be the biggest ever and could make Elon Musk a trillionaire

Business Insider

US stocks tumble and bond yields rise toward key levels as the Iran war heats up again

La Nacion

Récord de financiamiento externo: las empresas captaron más de US$6200 millones en el mercado en el primer cuatrimestre del año

CNA

Instant View: Anthropic IPO filing ratifies Wall Street's AI obsession

Expansion.com

Santander y BBVA se llevan cuatro de las siete mayores salidas a Bolsa del mundo

Diariobitcoin.com

Marvell se dispara en la bolsa tras comentarios de Jensen Huang de Nvidia sobre su futuro

Yahoo Entertainment

不僅封荷姆茲海峽！伊朗揚言闢新戰線美油價飆漲近8％

Metropoles.com

Dólar dispara e Bolsa afunda com "duplo tarifaço" e conflitos no Irã

El Financiero

¿Qué sabemos de Marvell, la próxima compañía tecnológica que valdrá 1 billón de dólares, según Nvidia?

Crypto Briefing

Arm’s stock surges nearly 100% in weeks, reaching $218B valuation on AI chip demand

New York Post

Gavin Newsom’s AI insiders set for $250M payday from Anthropic’s blockbuster IPO

Crypto Briefing

Putin confirms talks with US on potential military operation in Cuba, raising geopolitical risk for markets

CNA

Vanguard index product becomes first ETF to top $1 trillion in assets

El Financiero

Musk, cerca de ser trillonario: SpaceX busca recaudar 75 mil mdd en la mayor salida a bolsa de la historia

Al Jazeera English

Russia launches massive overnight attack on Ukraine

The Times of India

Did Berkshire Hathaway crack another long-term wealth-creation formula? NVR stock soared 62,000% since 1996, and its Taylor Morrison bet may signal the next homebuilder winner

PRNewswire

Supabase Raises $500M at $10.5B to Accelerate Lead in Agentic Infrastructure

Elperiodico.com

Alphabet venderá 80.000 millones de dólares en acciones para invertir en desarrollo de IA

The Times of India

Taiwan beefs up anti-ship missile arsenal to counter threat of Chinese invasion

PRNewswire

Demand for Compounding Pharmacies in USA to Reach USD 12.79 Billion by 2036 Amid Growing Need for Personalized Therapies and Specialized Medication Solutions